|
|
Home : Environmental Toxins : Mesothelioma : Newsfeeds : More Than Momentum: Stocks Rising for a Reason More Than Momentum: Stocks Rising for a Reason
Motley Fool - The protein, which has been shown to target cancer cells but spare healthy cells, is in phase 3 trials for the treatment of inoperable malignant mesothelioma. And the bet has been paying off lately -- Alfacell's stock has soared higher thanks to a ...
Find a Mesothelioma Lawyer Now
This form is secure and encrypted. More information about secure forms and your privacy here.
|




